Gapping down
In reaction to disappointing earnings/guidance: DOV -6.8%
M&A news:
In reaction to disappointing earnings/guidance: DOV -6.8%
M&A news:
- TWTR -13.1% (Bloomberg reports that potential suitors have lost interest, won't bid for the company)
Select EU financial related names showing weakness:
- RBS -2.2%, BCS -0.9%, PUK -0.9%, LYG -0.8%
Other news:
- OPTT -15.1% (launches underwritten public offering of 2.5 mln shares of its common stock)
- BMY -6.4% (several presentations at ESMO conf)
- TWLO -5.9% (files for $400 mln offering of common stock by it and various selling shareholders)
- NVO -1.8% (receives Complete Response Letter from the FDA regarding the New Drug Application for faster-acting insulin aspart)
- VIV -1.7% (appoints Eduardo Navarro as president and CEO of Telefonica Brazil)
Analyst comments:
- MYGN -5.4% (downgraded to Sell from Neutral at Ladenburg Thalmann)
- UTX -1.7% (downgraded to Neutral from Buy at Citigroup)
- NFLX -1.4% (initiated with a Sell at Deutsche Bank)
- HVT -0.8% (downgraded to Mkt Perform at Raymond James)